{"chunk_type":"transcript_chunk","text":"# Joint Pain Framework and Septic Arthritis Emergency\n## Top-down triage\n```\nJoint pain\n├── Monoarthritis\n│   ├── Septic arthritis (emergency)\n│   ├── Crystal arthropathy (gout/CPPD)\n│   └── Trauma/hemarthrosis\n├── Polyarthritis\n│   ├── Mechanical (OA)\n│   ├── Inflammatory systemic disease (RA, SpA, vasculitis)\n│   └── Other mimics\n└── Synovial fluid interpretation\n```\n\n## Synovial fluid WBC orientation\n| Category | Synovial WBC trend |\n| --- | --- |\n| Normal | <200 |\n| Non-inflammatory | 200-2,000 |\n| Inflammatory | 2,000-50,000 |\n| Septic concern | often >50,000 with neutrophil predominance |\n\n## Septic arthritis must-not-miss\n- Red/hot/swollen joint with severe pain on passive motion is emergency.\n- Arthrocentesis is essential for diagnosis and source characterization.\n- Prompt empiric IV antibiotics + joint drainage/washout are standard urgent steps.\n- Delays can rapidly destroy cartilage.\n\n## Pediatric septic hip pearl\n- Kocher-style criteria increase probability for septic arthritis.\n- If unclear, hip imaging/aspiration pathway is used to separate septic arthritis from transient synovitis.","subject":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","page_title":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","episode":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","section_path":["LM_OSRHM 30046f2986ee8098921dc4e04b63ee22"],"source_doc_id":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","source_page":null,"source_anchor":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22-41","focus_area":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"# Fight Bite, Disseminated Gonococcal Infection, OA, and Seronegative Back Pain\n## Fight bite (clenched-fist injury)\n- Small MCP laceration after punch-to-mouth can seed deep structures with oral polymicrobial flora.\n- Do not primarily close a contaminated fight-bite wound.\n- Management: irrigation/debridement + amoxicillin-clavulanate class coverage.\n\n## Disseminated gonococcal infection (DGI)\n- Two patterns: purulent monoarthritis or triad of migratory polyarthralgia + tenosynovitis + dermatitis.\n- Joint cultures may be negative; NAAT from mucosal sites is key.\n- Treatment: ceftriaxone-based regimen plus chlamydia co-treatment when indicated.\n\n## Osteoarthritis update\n- Mechanical pain pattern: worse with use, brief morning stiffness.\n- Typical hand distribution: DIP/PIP changes; MCP sparing is a clue against RA.\n- If MCP hook osteophytes pattern is present, evaluate iron-overload arthropathy context.\n\n## OA management ladder\n1. weight loss + strengthening exercise,\n2. topical NSAID,\n3. oral analgesic strategies,\n4. arthroplasty for end-stage functional loss.\n\n## Seronegative spondyloarthropathy core\n- Inflammatory back pain improves with activity and worsens with rest.\n- Ankylosing spondylitis: sacroiliitis progression, extra-articular uveitis risk.\n- Reactive arthritis: post-GU/GI trigger pattern with mucocutaneous/systemic signs.","subject":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","page_title":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","episode":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","section_path":["LM_OSRHM 30046f2986ee8098921dc4e04b63ee22"],"source_doc_id":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","source_page":null,"source_anchor":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22-61","focus_area":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"# HSP, Cryoglobulinemia, TMJ Dysfunction, and Joint Pain Rapid Recap\n## IgA vasculitis (HSP)\n- Typical pediatric pattern: palpable purpura (lower body), arthralgia/arthritis, abdominal pain, renal involvement.\n- GI complications (including intussusception) and urinalysis findings guide monitoring.\n\n## Cryoglobulinemic vasculitis\n- Strong association with hepatitis C.\n- Typical profile includes palpable purpura, weakness, arthralgias, low complement (especially C4).\n\n## TMJ dysfunction\n- Jaw pain/clicking with chewing, often linked to bruxism/stress.\n- Initial treatment is conservative: soft diet, night guard, NSAID-centered symptom control.\n\n## Rapid recap table\n| Condition | Key clue | Next step |\n| --- | --- | --- |\n| Septic arthritis | hot monoarthritis + severe movement pain | urgent arthrocentesis + IV antibiotics + drainage |\n| Gout | acute crystal inflammatory attack (often podagra) | crystal confirmation + anti-inflammatory therapy |\n| OA | mechanical pain with short morning stiffness | staged conservative-to-surgical management |\n| Fight bite | MCP wound after punch injury | no primary closure; debridement + oral-flora coverage |\n| DGI | tenosynovitis-dermatitis-migratory pain or purulent arthritis | NAAT-based confirmation + ceftriaxone regimen |\n| Ankylosing spondylitis | inflammatory back pain in younger patient | sacroiliac-focused evaluation and anti-inflammatory/biologic pathway |\n| HSP | palpable purpura + abdominal/renal signs in child | supportive care + renal/GI monitoring |","subject":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","page_title":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","episode":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","section_path":["LM_OSRHM 30046f2986ee8098921dc4e04b63ee22"],"source_doc_id":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","source_page":null,"source_anchor":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22-81","focus_area":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","tags":["usmle-step2","core","diagnosis","treatment","mnemonic","tree"]}
{"chunk_type":"transcript_chunk","text":"# Systemic Autoimmune Disorders Part 1: RA-SLE-MCTD Framework\n## Classification map\n```\nSystemic autoimmune disease\n├── Joint-predominant erosive disease: Rheumatoid arthritis\n├── Multi-organ immune-complex disease: SLE\n├── Overlap phenotype: MCTD (anti-U1-RNP)\n└── Thrombotic obstetric autoimmunity: APS\n```\n\n## Pattern-recognition principle\n- Diagnosis depends on joint distribution, stiffness pattern, organ involvement, and antibody profile rather than isolated arthralgia.\n\n## RA core\n- Symmetric inflammatory small-joint synovitis (MCP/PIP/wrist) with prolonged morning stiffness.\n- DIP sparing favors RA over OA hand pattern.\n- Anti-CCP is highly specific; ESR/CRP track activity.\n\n## RA high-risk complications\n| Complication domain | Example | Clinical consequence |\n| --- | --- | --- |\n| Cervical spine | C1-C2 instability | cord compression risk during airway manipulation |\n| Lung | interstitial disease | progressive dyspnea and functional decline |\n| Eye | scleritis/uveitis context | vision-threatening inflammation |\n| Vascular | accelerated atherosclerosis | increased MI/stroke risk |\n\n## RA treatment logic\n- Methotrexate-centered DMARD strategy with folate supplementation and toxicity surveillance.\n- Screen for latent TB/hepatitis before biologics.","subject":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","page_title":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","episode":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","section_path":["LM_OSRHM 30046f2986ee8098921dc4e04b63ee22"],"source_doc_id":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","source_page":null,"source_anchor":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22-101","focus_area":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"# Felty Syndrome and SLE Core Diagnostics\n## Felty syndrome\n- Long-standing erosive RA + splenomegaly + neutropenia.\n- Recurrent infection risk rises with severe neutropenia.\n\n## SLE profile\n- Young-woman predominant multisystem disease with fatigue, photosensitive rash, serositis, migratory non-erosive arthritis, renal/CNS risk.\n- Malar rash classically spares nasolabial folds.\n\n## Lupus nephritis\n- Major prognostic determinant.\n- Abnormal urinalysis/proteinuria/active sediment should trigger renal biopsy for class-based treatment decisions.\n\n## Antibody/complement map\n| Marker | Clinical use |\n| --- | --- |\n| ANA | sensitive screen |\n| anti-dsDNA | higher specificity; activity correlation (especially renal activity) |\n| anti-Smith | high specificity |\n| C3/C4 | low in active immune-complex consumption states |\n\n## Pregnancy differentiation pearl\n- Distinguish lupus flare from preeclampsia using inflammatory urine findings/complement context and full maternal-fetal assessment.","subject":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","page_title":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","episode":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","section_path":["LM_OSRHM 30046f2986ee8098921dc4e04b63ee22"],"source_doc_id":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","source_page":null,"source_anchor":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22-121","focus_area":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology","mnemonic"]}
{"chunk_type":"transcript_chunk","text":"# Drug-Induced Lupus, APS, and MCTD\n## Drug-induced lupus\n- Typical culprits include hydralazine/procainamide/isoniazid patterns.\n- Anti-histone positivity is classic.\n- Major renal/CNS lupus manifestations are less typical; stop culprit drug first.\n\n## Antiphospholipid syndrome (APS)\n- Clinical requirement: thrombosis and/or characteristic pregnancy morbidity.\n- Lab requirement: persistent positivity (repeat at least 12 weeks apart) among lupus anticoagulant, anticardiolipin, anti-beta2-glycoprotein I.\n- PTT can be prolonged despite prothrombotic in-vivo behavior.\n\n## APS treatment by setting\n| Clinical setting | Preferred anticoagulation strategy |\n| --- | --- |\n| Non-pregnant | warfarin-based long-term therapy |\n| Pregnancy | LMWH + low-dose aspirin |\n\n## MCTD\n- Overlap clinical phenotype spanning lupus/scleroderma/myositis features.\n- High-titer anti-U1-RNP is the key marker.\n- Raynaud and puffy hands are frequent pattern clues.","subject":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","page_title":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","episode":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","section_path":["LM_OSRHM 30046f2986ee8098921dc4e04b63ee22"],"source_doc_id":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","source_page":null,"source_anchor":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22-141","focus_area":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","tags":["usmle-step2","core","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"# Rapid Recap: Autoimmune Disorders Part 1 and Transition\n## Treatment/monitoring table\n| Disease context | Key therapy | High-yield caution |\n| --- | --- | --- |\n| RA | methotrexate-first DMARD axis | folate support; liver/marrow/lung toxicity surveillance |\n| SLE baseline | hydroxychloroquine | retinal monitoring for long-term use |\n| Lupus nephritis | class-directed immunosuppression | renal biopsy before regimen selection |\n| Drug-induced lupus | remove offending drug | anti-histone pattern helps confirmation |\n| APS in pregnancy | LMWH + aspirin | avoid warfarin in pregnancy |\n\n## Scenario anchors\n1. Anti-histone with culprit drug exposure -> drug-induced lupus.\n2. Puffy hands + Raynaud + overlap features -> evaluate anti-U1-RNP for MCTD.\n3. Pregnant hypertensive proteinuric patient with low complement/inflammatory urine -> lupus flare branch remains critical differential.\n4. Longstanding RA with UMN signs/cervical concern -> evaluate atlantoaxial instability urgently.\n5. Longstanding RA + recurrent infections + splenomegaly -> check ANC for Felty syndrome.\n6. New proteinuria in SLE -> renal biopsy pathway.\n\n## Transition\n- Next block focuses on seronegative spondyloarthropathies and connective-tissue fibrosis/dryness syndromes.","subject":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","page_title":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","episode":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","section_path":["LM_OSRHM 30046f2986ee8098921dc4e04b63ee22"],"source_doc_id":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","source_page":null,"source_anchor":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22-161","focus_area":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","tags":["usmle-step2","core","treatment","mnemonic"]}
{"chunk_type":"recap_summary","text":"# Seronegative Spondyloarthropathies and Connective Tissue Diseases Part 2\n## Big-picture split\n```\nPart 2 autoimmune map\n├── Seronegative spondyloarthropathies (RF-, often HLA-B27 linked)\n│   ├── Ankylosing spondylitis\n│   ├── Reactive arthritis\n│   └── Psoriatic arthritis\n└── Connective tissue disorders\n    ├── Sjogren syndrome\n    ├── Systemic sclerosis (limited vs diffuse)\n    └── Raynaud phenomenon\n```\n\n## SpA comparison table\n| Entity | Hallmark pattern | Core first-line approach |\n| --- | --- | --- |\n| Ankylosing spondylitis | inflammatory back pain + sacroiliitis | NSAID, then biologic escalation if refractory |\n| Reactive arthritis | post-GU/GI trigger with ocular/urogenital features | NSAID-centered care, treat persistent trigger infection |\n| Psoriatic arthritis | DIP disease, dactylitis, nail changes | phenotype-based anti-inflammatory/DMARD strategy |\n\n## AS details\n- Inflammatory back pain: improves with activity, worsens with rest/night.\n- Sacroiliitis is core imaging target; MRI can detect earlier inflammatory change.\n- Extra-articular risks: uveitis, aortic involvement, conduction abnormalities.","subject":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","page_title":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","episode":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","section_path":["LM_OSRHM 30046f2986ee8098921dc4e04b63ee22"],"source_doc_id":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","source_page":null,"source_anchor":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22-179","focus_area":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","tags":["usmle-step2","core","recap","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"# Sjogren, Systemic Sclerosis, and Raynaud Management Pearls\n## Sjogren syndrome\n- Sicca syndrome: gritty dry eyes and xerostomia with swallowing difficulties.\n- Often associated with anti-Ro/SSA and anti-La/SSB positivity.\n\n## Diagnostic anchors\n- Schirmer testing for tear production.\n- Minor salivary gland (lip) biopsy supports diagnosis in selected uncertain cases.\n\n## High-risk complication\n- Increased risk of B-cell lymphoma (especially MALT-type patterns) with persistent glandular enlargement or systemic alarm signs.\n\n## Systemic sclerosis framework\n| Subtype | Typical antibody | Dominant organ risk |\n| --- | --- | --- |\n| Limited cutaneous (CREST pattern) | anti-centromere | pulmonary arterial hypertension/vascular phenotype |\n| Diffuse cutaneous | anti-Scl-70 | interstitial lung disease and renal crisis risk |\n\n## Scleroderma renal crisis (emergency)\n- Sudden severe hypertension + AKI requires urgent ACE inhibitor strategy.\n- Early creatinine rise does not preclude lifesaving ACE inhibition.\n\n## Raynaud phenomenon\n- Triphasic vasospastic color change (white-blue-red) with cold/stress.\n- Evaluate for secondary autoimmune disease in severe/asymmetric or progressive presentations.","subject":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","page_title":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","episode":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","section_path":["LM_OSRHM 30046f2986ee8098921dc4e04b63ee22"],"source_doc_id":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","source_page":null,"source_anchor":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22-189","focus_area":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","tags":["usmle-step2","core","diagnosis","treatment","mnemonic","tree"]}
{"chunk_type":"transcript_chunk","text":"# Systemic Sclerosis and Raynaud Management Pearls\n## Systemic sclerosis framework\n- Disease process combines vasculopathy, immune activation, and progressive fibrosis.\n- Limited cutaneous pattern (CREST, anti-centromere) vs diffuse pattern (anti-Scl-70 with higher visceral risk).\n\n## Organ risk profile\n| Subtype | Major risk emphasis |\n| --- | --- |\n| Limited | pulmonary arterial hypertension and chronic vascular features |\n| Diffuse | interstitial lung disease and renal crisis risk |\n\n## Scleroderma renal crisis (emergency)\n- Sudden severe hypertension + AKI requires urgent ACE inhibitor strategy.\n- Early creatinine rise does not preclude lifesaving ACE inhibition.\n\n## Raynaud phenomenon\n- Triphasic vasospastic color change (white-blue-red) with cold/stress.\n- Evaluate for secondary autoimmune disease in severe/asymmetric or progressive presentations.","subject":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","page_title":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","episode":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","section_path":["LM_OSRHM 30046f2986ee8098921dc4e04b63ee22"],"source_doc_id":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","source_page":null,"source_anchor":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22-209","focus_area":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
